NEW YORK (Reuters Health) – Based on their review of screening instruments for alcohol and drug misuse, a Canadian team recommends using three quick questions in the emergency…
NEW YORK (Reuters Health) – The excess risk of unexplained sudden death in psychiatric patients may be related to diabetes and dyslipidemia rather than to the antipsychotic drugs…
Teresa L. Knight, MD, FACOG, Chief Medical Officer of the Women’s Health Specialists of Saint Louis, discusses the phenomenon of postpartum blues, or “baby blues”. To learn more…
Lena Edwards, MD, internist and President of the Balance Health & Wellness Center, discusses adrenal fatigue. For more information on the Balance Health & Wellness Center, please visit:…
NEW YORK (Reuters Health) – Clonidine in the form of extended-release tablets improves response to psychostimulant treatment in children and adolescents with attention-deficit/hyperactivity disorder, results of a phase…
NEW YORK (Reuters Health) – Bupropion sustained release (SR) contributes to smoking cessation efforts in patients with schizophrenia, according to a report in the April 5th online Journal…
NEW YORK (Reuters Health) – Brief behavioral therapy can reduce insomnia in patients with residual depression, researchers report in the March 8th online Journal of Clinical Psychiatry. “We…
NEW YORK (Reuters Health) – In a new study testing the efficacy of atomoxetine in young children with ADHD, kids on the drug improved on some measures of…
Lena Edwards, MD, internist, Balance Health & Wellness Center, discusses stress and anxiety. Depression and anxiety are directly linked to HPA (hypothalamic-pituitary-adrenal axis) and increase in cortisol. SSRIs…
NEW YORK (Reuters Health) – Long-term treatment with the atypical antipsychotic asenapine prevents relapse of schizophrenia and is well tolerated, according to a report in the Journal of…